What Lymphoma Patients Need to Know About Current Treatments for COVID-19
As of mid-2022, there are a number of treatments for COVID-19 that have been either approved by the FDA or have been authorized for emergency use (EUA).
News
Lymphoma Research Foundation Names Sarah Quinlan Chief Program Officer
Lymphoma Research Foundation Names Sarah Quinlan Chief Program Officer The Lymphoma Research Foundation (LRF) – the nation’s largest non-profit organization dedicated exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensive series of education programs, outreach…
U.S. Food and Drug Administration Approves Lisocabtagene Maraleucel (BREYANZI) for Large B-Cell Lymphoma
The U.S. Food and Drug Administration Approves Lisocabtagene Maraleucel (Breyanzi) for Large B-Cell Lymphoma On June 24, 2022, the U.S. Food and Drug Administration (FDA) announced it has approved the use of lisocabtagene maraleucel (liso-cel, Breyanzi), a chimeric antigen receptor…
U.S. Food and Drug Administration Approves CAR T Cell Therapy for Follicular Lymphoma
FDA announced it has approved the use of tisagenlecleucel (Kymriah, Novartis Pharmaceuticals Corporation) for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) after two or more lines of systemic therapy.
Meet the 2022 Career Development Award, Postdoctoral Fellowship, and Follicular Lymphoma Priority Research Grantees
The Lymphoma Scientific Research Mentoring Program (LSRMP) is a first-of-its-kind education and mentoring program for junior scientists who wish to focus on lymphoma clinical and laboratory/translational research.
Advocating for Answers
After 20 years of living with lymphoma, Lois Rosenblum knows firsthand the importance of a strong support system and advocating
for your health. Following an initial diagnosis of follicular lymphoma in 2002 and several disease transformations since then, she’s passionate about supporting the work that the Lymphoma Research Foundation (LRF) does to power cutting-edge research to treat and defeat lymphoma.
Where Are They Now? Carla Casulo, MD
Dr. Carla Casulo is a medical oncologist at the University of Rochester Medical Center.
Lymphoma Research Foundation’s 2022 North American Educational Forum on Lymphoma To be Held Virtually
LRF announced today that its premier patient education program, the 2022 North American Educational Forum on Lymphoma, will be held virtually from Friday, October 28th to Sunday, October 30th.
Curiosity in Pursuit of a Cure
LRF grantee Abner Louissaint, MD, PhD has been interested in studying things since he was a child. His inquisitiveness followed him
through his adult years and was a catalyst for his desire to pursue a career in the study of lymphoma.
Patient Perspectives: Dispelling Myths About Clinical Trials
Clinical trials are important for advancing research and can provide patients with access to the most cutting-edge treatments. LRF Associate Director of Support Services and Helpline specialist, Izumi Nakano, answers some common questions about clinical trials to help better understand the process and what to think about when considering enrolling in one.